Open AccessPathogen Inactivation of Cellular Blood Products – More Security for the Patient or Less?
Author(s) -
G. Caspari,
Wolfram H. Gerlich,
Lutz Gürtler
Publication year - 2003
Publication title -
transfusion medicine and hemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.971
H-Index - 39
eISSN - 1660-3818
pISSN - 1660-3796
DOI - 10.1159/000075859
Subject(s) - residual risk , blood product , sepsis , medicine , human immunodeficiency virus (hiv) , blood transfusion , intensive care medicine , immunology , platelet transfusion , pathogen , risk of infection , serology , platelet , hepatitis c , whole blood , virology , biology , surgery , antibody , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom